Cefepime/Enmetazobactam vs Piperacillin/Tazobactam and Complicated Urinary Tract Infection or Acute Pyelonephritis-Reply

JAMA. 2023 Feb 28;329(8):685. doi: 10.1001/jama.2022.22873.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Cefepime / therapeutic use
  • Humans
  • Piperacillin / adverse effects
  • Pyelonephritis* / drug therapy
  • Tazobactam / therapeutic use
  • Urinary Tract Infections* / drug therapy

Substances

  • Cefepime
  • enmetazobactam
  • Piperacillin
  • Tazobactam